Vericel Corp SEC filings VCEL
Vericel Corp has 1,002 filings in SEC EDGAR's recent list, going back to Aug 7, 2013. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 19, 2026 | — |
| DEF 14A | Proxy statement | Mar 19, 2026 | Apr 29, 2026 |
| DEFA14A | Additional proxy material | Mar 20, 2025 | — |
| DEF 14A | Proxy statement | Mar 20, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Mar 21, 2024 | — |
| DEF 14A | Proxy statement | Mar 21, 2024 | May 1, 2024 |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | — |
| DEFA14A | Additional proxy material | Mar 17, 2022 | — |
| DEF 14A | Proxy statement | Mar 17, 2022 | Apr 27, 2022 |
| DEFA14A | Additional proxy material | Mar 19, 2021 | — |
| DEF 14A | Proxy statement | Mar 19, 2021 | Apr 28, 2021 |
| DEFA14A | Additional proxy material | Apr 10, 2020 | — |
| DEF 14A | Proxy statement | Mar 20, 2020 | Apr 29, 2020 |
| DEF 14A | Proxy statement | Mar 20, 2019 | May 1, 2019 |
| DEF 14A | Proxy statement | Mar 22, 2018 | May 2, 2018 |
| DEF 14A | Proxy statement | Mar 20, 2017 | May 3, 2017 |
| DEF 14A | Proxy statement | Mar 18, 2016 | May 4, 2016 |
| DEF 14A | Proxy statement | Mar 25, 2015 | May 12, 2015 |
| DEF 14A | Proxy statement | Oct 21, 2014 | Nov 21, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2014 | Oct 9, 2014 |
| DEFA14A | Additional proxy material | May 1, 2014 | — |
| DEF 14A | Proxy statement | Mar 31, 2014 | May 7, 2014 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2014 | May 7, 2014 |
| DEF 14A | Proxy statement | Sep 5, 2013 | Oct 7, 2013 |
| PRE 14A | Preliminary proxy statement | Aug 26, 2013 | Oct 7, 2013 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VCEL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Burlington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 887359
- Former names
- AASTROM BIOSCIENCES INC (until Nov 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.